ClinVar Miner

Submissions for variant NM_001101.5(ACTB):c.490C>T (p.Pro164Ser)

dbSNP: rs1784814856
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001230098 SCV001402568 uncertain significance Baraitser-Winter syndrome 1 2019-11-03 criteria provided, single submitter clinical testing This variant has not been reported in the literature in individuals with ACTB-related conditions. This sequence change replaces proline with serine at codon 164 of the ACTB protein (p.Pro164Ser). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and serine. This variant is not present in population databases (ExAC no frequency). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C65"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Institute of Human Genetics, Heidelberg University RCV001230098 SCV004185535 pathogenic Baraitser-Winter syndrome 1 2023-12-15 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.